Spotted on
Nouscom
Nouscom develops cancer vaccines using engineered viral vectors that teach the immune system to recognize and attack tumor cells. The Basel based biotech is in clinical trials for Lynch syndrome and metastatic colorectal cancer.
TECHnicalBeep
Sponsored by:
technicalbeep.com/maps/startups/nouscom
European ecosystem maps